The diabetic patient admitted to hospital with serious pneumonia on October 14 immediately received a combined therapy that included doses of Remdesivir, the university said, adding that the therapy had significantly improved her condition.

The patient is now convalescing in her home, it added.

According to the university, 19 patients have so far received Remdesivir manufactured by Hungarian pharma company Richter Gedeon.

Remdesivir, a virus inhibitor, is given to Covid-19 patients hospitalised with a serious condition.

Clinical trials of Richter’s Remdesivir in Hungary started in mid-October, with all four medical universities of the country participating.

The drug was approved by the US Food and Drug Administration on October 22.


MTI Photo: Zsolt Czeglédi